In some diseases, a complex may be aberrantly active; for example, in acute leukemia the MLL gene is translocated, resulting in fusion proteins between an N-terminal fragment of MLL and over 50 different target proteins (Liu et al., 2009). This evidence concerns the gene KMT2A and acute leukemia.